Skp2 Controls Adipocyte Proliferation during the Development of Obesity
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The increase in the mass of adipose tissue during the development of obesity can arise through an increase in cell size, an increase in cell number, or both. Here we show that long term maintenance of C57BL/6 mice on a high fat diet (for ∼25 weeks) induces an initial increase in adipocyte size followed by an increase in adipocyte number in white adipose tissue. The latter effect was found to be accompanied by up-regulation of expression of the gene for the F-box protein Skp2 as well as by downregulation of the cyclin-dependent kinase inhibitor p27Kip1, a principal target of the SCFSkp2 ubiquitin ligase, in white adipose tissue. Ablation of Skp2 protected mice from the development of obesity induced either by a high fat diet or by the lethal yellow agouti (Ay) mutation, and this protective action was due to inhibition of the increase in adipocyte number without an effect on adipocyte hypertrophy. The reduction in the number of adipocyte caused by Skp2 ablation also inhibited the development of obesity-related insulin resistance in the Ay mutant mice, although the reduced number of β cells and reduced level of insulin secretion in Skp2-deficient mice resulted in glucose intolerance. Our observations thus indicate that Skp2 controls adipocyte proliferation during the development of obesity. The increase in the mass of adipose tissue during the development of obesity can arise through an increase in cell size, an increase in cell number, or both. Here we show that long term maintenance of C57BL/6 mice on a high fat diet (for ∼25 weeks) induces an initial increase in adipocyte size followed by an increase in adipocyte number in white adipose tissue. The latter effect was found to be accompanied by up-regulation of expression of the gene for the F-box protein Skp2 as well as by downregulation of the cyclin-dependent kinase inhibitor p27Kip1, a principal target of the SCFSkp2 ubiquitin ligase, in white adipose tissue. Ablation of Skp2 protected mice from the development of obesity induced either by a high fat diet or by the lethal yellow agouti (Ay) mutation, and this protective action was due to inhibition of the increase in adipocyte number without an effect on adipocyte hypertrophy. The reduction in the number of adipocyte caused by Skp2 ablation also inhibited the development of obesity-related insulin resistance in the Ay mutant mice, although the reduced number of β cells and reduced level of insulin secretion in Skp2-deficient mice resulted in glucose intolerance. Our observations thus indicate that Skp2 controls adipocyte proliferation during the development of obesity. The worldwide epidemic of obesity is a serious threat to public health, in part because the increase in the mass of white adipose tissue (WAT) 2The abbreviations used are: WAT, white adipose tissue; CDK, cyclin-dependent kinase; CKI, cyclin-dependent kinase inhibitor; Rb, retinoblastoma protein; SCF, Skp1-Cullin-F-box protein; PDK1, phosphoinositide-dependent kinase 1; Erk, extracellular signal-regulated kinase; E3, ubiquitin-protein isopeptide ligase. in obese individuals increases the risk for development of insulin resistance and type 2 diabetes mellitus (1Yach D. Stuckler D. Brownell K.D. Nat. Med. 2006; 12: 62-66Crossref PubMed Scopus (638) Google Scholar). The expansion of WAT during the development of obesity can occur through increases in cell number (adipocyte hyperplasia) and in cell size (adipocyte hypertrophy) (2Haslam D.W. James W.P. Lancet. 2005; 366: 1197-1209Abstract Full Text Full Text PDF PubMed Scopus (3674) Google Scholar, 3Hausman D.B. DiGirolama M. Bartness T.J. Hausman G.J. Martin R.J. Obesity Rev. 2001; 2: 239-254Crossref PubMed Scopus (530) Google Scholar). However, the precise contribution of adipocyte number to the pathogenesis of obesity and obesity-related insulin resistance remains unclear. The number of adipocytes is thought to increase as a result of the proliferation of preadipocytes and their subsequent differentiation into mature adipocytes (4Bjorntorp P. Horm. Metab. Res. 1974; 4: 77-83PubMed Google Scholar, 5Spiegelman B.M. Flier J.S. Cell. 1996; 87: 377-389Abstract Full Text Full Text PDF PubMed Scopus (1173) Google Scholar). Both the proliferation and differentiation of preadipocytes are characterized by marked changes in the pattern of gene expression that are achieved by the sequential induction of various transcription factors, including members of the CCAAT/enhancer-binding protein (C/EBP-α,-β, and -δ), peroxisome proliferator-activated receptor (PPAR-γ,-β, and -δ), basic helix-loop-helix (SREBP-1c), and Kruppel-like zinc-finger factor (KLF-5 and -15) families (6Oishi Y. Manabe I. Tobe K. Tsushima K. Shindo T. Fujiu K. Nishimura G. Maemura K. Yamauchi T. Kubota N. Suzuki R. Kitamura T. Akira S. Kadowaki T. Nagai R. Cell Metab. 2005; 1: 27-39Abstract Full Text Full Text PDF PubMed Scopus (360) Google Scholar, 7Mori T. Sakaue H. Iguchi H. Gomi H. Okada Y. Takashima Y. Nakamura K. Nakamura T. Yamauchi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Uchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., Kido, Y., Hayashi, Y., Nakayama, K. I., White, M. F., et al. (2005) · Nature Medicine · doi:10.1038/nm1187 · Cited by 218
Self-citation
Cited by
Roles of F-box proteins in cancer
Wang, Z., Liu, P., Inuzuka, H., & Wei, W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3700 · Cited by 523
Chan, C.-H., Morrow, J. K., Li, C.-F., Gao, Y., Jin, G., Moten, A., Stagg, L. J., Ladbury, J. E., Cai, Z., Xu, D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.048 · Cited by 391
“…metabolism and therefore endow cancer development, but it also plays an essential role in other metabolic disorders, such as obesity, evidenced by a previous report demonstrating that Skp2 ablation protects mice from developing obesity through reducing adipocyte proliferation (Sakai et al., 2007).”
Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M., Yamahara, K., Taura, D., Inuzuka, M., Sonoyama, T., et al. (2009) · Diabetes · doi:10.2337/db09-0393 · Cited by 288
Joe, A. W. B., Yi, L., Even, Y., Vogl, A. W., & Rossi, F. M. V. (2009) · Stem Cells · doi:10.1002/stem.190 · Cited by 279
The FoxO transcription factors and metabolic regulation
Nakae, J., Oki, M., & Cao, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.025 · Cited by 176
“Furthermore, Skp2 is also involved in regulation of glucose metabolism, which includes the regulation of number of pancreatic b-cell, insulin secretion and adipocyte proliferation during the development of obesity [59].”
Background
Metadata
- Authors
- Sakai, T., Sakaue, H., Nakamura, T., Okada, M., Matsuki, Y., Watanabe, E., Hiramatsu, R., Nakayama, K., Nakayama, K. I., & Kasuga, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 282
- Issue
- 3
- Pages
- 2038-2046
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2088418379
- Cited by
- 80
- References
- 2
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.